Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Go back to Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 196.58 -2.09 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $198.67 | 52 Week High | $333.65 | |||
| Open | $200.22 | 52 Week Low | $223.02 | |||
| Day High | $200.99 | P/E | 25.17 | |||
| Day Low | $193.20 | EPS | $7.81 | |||
| Volume | 1,729,827 | |||||
| (NASDAQ: IONS) | Delayed: 74.12 -0.19 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.31 | 52 Week High | $62.68 | |||
| Open | $75.00 | 52 Week Low | $19.59 | |||
| Day High | $75.66 | P/E | N/A | |||
| Day Low | $73.50 | EPS | $0.00 | |||
| Volume | 2,984,375 | |||||
